study (56) – we could ask two critical questions that need further investigation: (i) would RECK downregulation lends itself to increased invasion of inflammatory cells into the liver in cases of NAFLD and NASH? The gene discussed is RECK; the disease is metabolic dysfunction-associated steatotic liver disease.